These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36773455)

  • 1. Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity.
    Kaur M; Muzzammel Rehman H; Kaur G; Kaur A; Bansal M
    Bioorg Chem; 2023 Apr; 133():106406. PubMed ID: 36773455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
    Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
    Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
    Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
    Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
    Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
    Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
    Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
    Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.
    Munir A; Khushal A; Saeed K; Sadiq A; Ullah R; Ali G; Ashraf Z; Ullah Mughal E; Saeed Jan M; Rashid U; Hussain I; Mumtaz A
    Bioorg Chem; 2020 Nov; 104():104168. PubMed ID: 32947133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New benzimidazothiazole derivatives as anti-inflammatory, antitumor active agents: Synthesis, in-vitro and in-vivo screening and molecular modeling studies.
    El-Kerdawy MM; Ghaly MA; Darwish SA; Abdel-Aziz HA; Elsheakh AR; Abdelrahman RS; Hassan GS
    Bioorg Chem; 2019 Mar; 83():250-261. PubMed ID: 30391698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
    Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
    Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
    Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and molecular docking studies of new azomethine derivatives as promising anti-inflammatory agents.
    Desai SR; Desai VG; Pissurlenkar RR
    Bioorg Chem; 2022 Mar; 120():105595. PubMed ID: 35074576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
    Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 5-Methylthiazole-Thiazolidinone Conjugates as Potential Anti-Inflammatory Agents: Molecular Target Identification and In Silico Studies.
    Haroun M; Petrou A; Tratrat C; Kolokotroni A; Fesatidou M; Zagaliotis P; Gavalas A; Venugopala KN; Sreeharsha N; Nair AB; Elsewedy HS; Geronikaki A
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New ursolic acid derivatives bearing 1,2,3-triazole moieties: design, synthesis and anti-inflammatory activity in vitro and in vivo.
    Zhang TY; Li CS; Cao LT; Bai XQ; Zhao DH; Sun SM
    Mol Divers; 2022 Apr; 26(2):1129-1139. PubMed ID: 34080112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tilomisole-based benzimidazothiazole derivatives as anti-inflammatory agents: Synthesis, in vivo, in vitro evaluation, and in silico studies.
    Darwish SA; El-Kerdawy MM; Elsheakh AR; Abdelrahman RS; Shaldam MA; Abdel-Aziz HA; Hassan GS; Ghaly MA
    Bioorg Chem; 2022 Mar; 120():105644. PubMed ID: 35121552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
    Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents.
    Jan MS; Ahmad S; Hussain F; Ahmad A; Mahmood F; Rashid U; Abid OU; Ullah F; Ayaz M; Sadiq A
    Eur J Med Chem; 2020 Jan; 186():111863. PubMed ID: 31740050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.